Eton Pharmaceuticals, Inc. (ETON)

Last Closing Price: 29.13 (2026-06-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Eton Pharmaceuticals, Inc. (ETON) had Net Income of $1.55M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$24.27M
Net Income
$1.55M
$9.53M
$14.73M
$21.85M
$2.41M
$-0.84M
$1.57M
$1.57M
$1.55M
$1.55M
$1.55M
$1.55M
$2.41M
$3.66M
27.29M
31.55M
$0.06
$0.05
Balance Sheet Financials
$53.24M
$0.37M
$44.47M
$97.71M
$44.18M
$18.94M
$22.92M
$67.09M
$30.61M
$-13.12M
$30.61M
27.36M
Cash Flow Statement Financials
$7.41M
$-15.07M
$1.39M
$25.94M
$19.66M
$-6.28M
$1.52M
--
--
Fundamental Metrics & Ratios
1.21
--
--
0.38
1.00
60.72%
9.95%
9.95%
--
6.49%
6.40%
$7.33M
--
--
--
0.25
0.66
1.81
49.73
5.08%
-11.84%
1.59%
3.14%
$1.12
$0.23
$0.23